Subscribe


PD breaking news – Medicines Regulation inquiry calls for comp meds submissions

Questions about efficacy testing, non-compliance deterrents posed. 

The panel conducting the Review of Medicines and Medical Devices Regulation has called for submissions from stakeholders regarding regulation of complementary medicines.

The panel, headed by Emeritus Professor Lloyd Sansom and announced last year (PD 27 Oct 14), released an addendum to its discussion paper today dealing with complementary medicines.

The chapter, which was flagged at the time of the Review’s announcement, asks various questions of stakeholders, including whether an ingredient should only be considered to have been ‘approved’ by an overseas regulator if it had been subjected to assessment, and if so, whether this assessment should include quality, safety and efficacy.

The document said while Canadian regulators undertook pre-market evaluation of ingredients in complementary medicines for quality, safety and efficacy, the US Food and Drug Administration only require notification of a new ingredient and demonstration of a reasonable expectation of safety for use in a dietary supplement.

“As such, ‘approval’ of a new ingredient in Canada means something quite different than ‘approval’ of a new ingredient in the US.

“In Australia, the TGA assesses quality and safety of a new ingredient, but does not undertake an assessment of efficacy.”

Other questions asked of stakeholders include whether Australia should adopt approval of ingredients by ‘trusted’ overseas regulators, whether the current regulatory regime for complementary medicines in Australia is commensurate with the risk posed by products, and whether low-risk complementary medicines should be regulated as general consumer goods, rather than having to be listed on the Australian Register of Therapeutic Goods.

The chapter also asks whether current legislation provided sufficient deterrents to prevent sponsors “knowingly listing non-compliant complementary medicines” on the Register, citing the fact that sponsors could request a product be removed from the Register if it is subjected to a review by the Therapeutic Goods Administration, and re-list it at a later date.

Submissions on the addendum are due by 08 Apr.

For more, see Monday’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 20 Feb 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

24 Nov

Events Calendar 24 Nov 17 - 5-8 Dec: APSA-ASCEPT 2017 Joint Scientific Meeting; ...


24 Nov

Dispensary Corner 24 Nov 17 - TASMANIAN pharmacist Michael Meaney from Shearwater Amcal ...


24 Nov

$20k from Guild for Mirabel - YESTERDAY Victorian Health Minister Jill Hennessy handed ...


24 Nov

Benzac range boost - GALDERMA has announced the launch of Benzac ...


24 Nov

Breast cancer drug - A new licensing deal by Specialised Therapeutics ...


24 Nov

UK ADE campaign - BRITAIN'S Medicines and Healthcare products Regulatory Agency ...


24 Nov

Codral ads withdrawn - JOHNSON & Johnson Pacific has been ordered ...


24 Nov

Guild rejigs consumer facing websites - THE Pharmacy Guild has combined its 'Find ...


24 Nov

TGA codeine training - HEALTH professionals dealing with chronic and acute ...


24 Nov

FDA issues generic opioid guidance - THE US Food and Drug Administration has ...


24 Nov

Terry White tops Oct satisfaction stakes - THE Terry White brand has come out ...


24 Nov

Semenax warning - THE Therapeutic Goods Administration has found that ...


24 Nov

Assisted dying passes - VICTORIA'S parliament has approved new assisted-dying laws ...


24 Nov

NPS osteoarthritis tips - NPS MedicineWise, in an effort to reduce ...


24 Nov

Cannabis medicines in SAS - LISTED Australian medicinal cannabis company Medlab has ...


24 Nov

Amgen details direct move - AMGEN says changes to the distribution model ...


23 Nov

Travel Specials 23 Nov 17 - CARNIVAL Cruise Line's Spoil Yourself Silly Sale ...


23 Nov

Dispensary Corner 23 Nov 17 - THOSE inventive people at KFC have done ...


23 Nov

CW supply contract - CHEMIST Warehouse has issued a formal tender ...


23 Nov

PBS mandatories - INCLUDING a pharmacy's Chemotherapy Compounder ID will ...



Show Pharmacy Daily items by month: